New hope for cancer patients with fluid in the chest or belly
NCT ID NCT04914598
First seen Jan 10, 2026 · Last updated May 14, 2026 · Updated 16 times
Summary
This study tests whether adding Endostar to standard cisplatin treatment helps cancer patients with malignant pleural effusion or ascites (fluid buildup in the chest or belly) go longer without needing another drainage procedure. About 290 adults whose fluid is not well controlled after prior treatments will receive either Endostar or a placebo, both with cisplatin, injected into the body cavity. The goal is to see if the combination delays the need for repeat drainage.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT PLEURAL EFFUSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Yan Xie
Nanjing, China
Conditions
Explore the condition pages connected to this study.